LLNL Researchers aid COVID-19 response in anti-viral research

Backed by five high performance computing (HPC) clusters and years of expertise in vaccine and countermeasure development, a COVID-19 response team of LLNL researchers from various disciplines has used modeling & simulation, along with machine learning, to identify about 20 initial, yet promising, antibody designs from a nearly infinite set of potentials and to examine millions of small molecules that could have anti-viral properties. The candidates will need to be synthesized and experimentally tested - which Lab researchers cautioned could take time - but progress is being made.

The post LLNL Researchers aid COVID-19 response in anti-viral research appeared first on insideHPC.